GLP-1 medications for weight management are FDA-approved for adults who meet one of the following criteria: BMI 30 (obesity), or BMI 27 (overweight) with at least one weight-related condition: Type 2 diabetes, hypertension, high cholesterol, sleep apnea, cardiovascular disease, or MASLD/NAFLD A complete medical evaluation is required before starting any GLP-1 therapy at MWLI
The active form of B12 in shots or injections typically refers to methylcobalamin or adenosylcobalamin, which are bioavailable and readily utilized by the body for essential functions like energy production, nervous system health, and red blood cell formation
Between January 2024 and June 2025, first-time prescribing increased at an average rate of 0.01 percentage points per month, a 239% gain over the period
This revitalizing treatment delivers essential hydration, nausea relief, and replenishes vital minerals, promoting optimal recovery and enhancing overall well-being